Atomera INC

Atomera Incorporated's 2026 Annual Meeting saw the election of directors, ratification of auditors, and approval to increase authorized shares.

Atomera Incorporated announced its first quarter 2026 financial results, highlighting progress in MST adoption for Gate-All-Around transistors and expansion into RF applications with Gallium Nitride (GaN) technology, alongside a $25 million equity raise.

Atomera Incorporated announced a registered direct offering of 5 million common shares at $5.00 each, raising $25 million in gross proceeds for working capital and general corporate purposes.

Atomera Incorporated reported a net loss of $20.2 million for fiscal year 2025, an increase from the prior year, with revenue declining by more than 50%.

Atomera Incorporated announced its fourth quarter and fiscal year 2025 financial results, highlighting technical breakthroughs and initial commercial adoption of its MST technology.

Atomera Incorporated's Board of Directors approved amended bylaws, reducing the quorum for stockholder meetings and altering voting requirements for non-director election matters.

Atomera Incorporated reported its first quarter 2026 financial results, highlighting increased revenue and successful capital raises to support ongoing operations and technology development.

Atomera Incorporated reported a significant increase in net loss for the third quarter and first nine months of 2025, driven by declining revenue and higher operating expenses, while continuing to raise capital through an at-the-market offering.

Atomera Incorporated reported increased net losses and minimal revenue for Q2 2025, continuing to rely on at-the-market equity offerings for liquidity while addressing internal control weaknesses.

Atomera Incorporated's Q1 2025 results show a decrease in revenue and continued operating losses, but the company believes it has sufficient capital for the next 12 months.

Atomera Incorporated reported its third quarter 2024 financial results, highlighting ongoing efforts in the development and commercialization of its MST technology.

Atomera Incorporated reported a net loss of $9.183 million for the first half of 2024, with limited revenue generation and ongoing research and development efforts.

Atomera Incorporated reported a significant increase in net loss for fiscal year 2025, driven by higher operating expenses, while securing substantial post-period financing to extend its operational runway.

Atomera Inc.'s 2024 10-K filing reveals ongoing efforts to commercialize its MST technology amidst continued operating losses and reliance on equity financing.

Atomera Incorporated's 2023 annual report details the company's progress in commercializing its MST technology, including its first full commercial license agreement and ongoing joint development efforts.

Atomera Inc. Chief Technology Officer Robert J. Mears sold 1,000 shares of common stock for $8.40 per share under a pre-arranged 10b5-1 trading plan.

Atomera Chief Technology Officer Robert J. Mears exercised options and sold shares under a pre-established Rule 10b5-1 trading plan.

Atomera CFO Francis Laurencio exercised options for 20,400 shares and subsequently sold the same amount on June 15, 2026.

Atomera CEO Scott Bibaud exercised 50,000 stock options and subsequently sold the shares on June 15, 2026.

Atomera Inc. reports that Chief Technology Officer Robert J. Mears executed a series of stock transactions under a pre-arranged Rule 10b5-1 trading plan.

Atomera Inc. CEO Scott Bibaud sold company stock to cover tax obligations related to vested restricted stock grants, a transaction executed under a Rule 10b5-1(c) plan.

Atomera Incorporated announced its 2026 Annual Meeting of Stockholders, where key proposals include director elections, auditor ratification, an increase in authorized common stock, and an advisory vote on executive compensation.

Atomera Inc. releases a supplement to its proxy statement, clarifying stock incentive plan details and modifying the CEO's severance terms related to a change of control.

Atomera Inc. issues a supplement to its proxy statement regarding the approval requirements for Amendment No. 1 to the company's 2023 Stock Incentive Plan.

Atomera Inc. has filed a definitive proxy statement with the SEC, signaling upcoming shareholder actions.

Atomera Incorporated is asking stockholders to approve an amendment to its 2023 Stock Incentive Plan to increase the number of shares available for issuance.

Atomera Inc. will hold its annual stockholder meeting virtually on May 1, 2024, and the board recommends voting for all director nominees and proposals related to auditor ratification and executive compensation.

CVI Investments, Inc. and Heights Capital Management, Inc. have filed a Schedule 13G, reporting 0% beneficial ownership of Atomera Incorporated's common stock as of March 31, 2026.

The Vanguard Group has amended its Schedule 13G filing for Atomera Inc., reporting 0% beneficial ownership following an internal realignment that shifts reporting to its subsidiaries.

CVI Investments, Inc. and Heights Capital Management, Inc. jointly report beneficial ownership of 5.8% of Atomera Incorporated's common stock.

The Vanguard Group has reported a passive beneficial ownership of 5.27% in Atomera Inc.'s common stock, totaling 1,620,488 shares.

BlackRock, Inc. has reported a 5.6% beneficial ownership stake in ATOMERA INC, holding 1,720,244 shares of common stock as of June 30, 2025.